Assessing the effect of ondansetron on peripheral vertigo
Phase 3
Recruiting
- Conditions
- acute peripheral vertigo.Disorders of vestibular function
- Registration Number
- IRCT20180129038543N1
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Having acute peripheral vertigo
Symptoms of vertigo include severe dizziness, attack with and without severe nausea
age between 20-60 years
Exclusion Criteria
New associated neurological symptoms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vertigo score in the questionnaire. Timepoint: Before injection; 30 minutes later and 2 hours after prescribing. Method of measurement: visual analogue scale, reliefe score,questionnaire.
- Secondary Outcome Measures
Name Time Method